Pharmaceutisch weekblad. Scientific edition最新文献

筛选
英文 中文
Continuation and maintenance therapy with antidepressive agents. Meta-analysis of research (II) 抗抑郁药物的继续和维持治疗。研究荟萃分析(二)
Pharmaceutisch weekblad. Scientific edition Pub Date : 1992-04-24 DOI: 10.1007/BF01980485
J M Keppel Hesselink
{"title":"Continuation and maintenance therapy with antidepressive agents. Meta-analysis of research (II)","authors":"J M Keppel Hesselink","doi":"10.1007/BF01980485","DOIUrl":"https://doi.org/10.1007/BF01980485","url":null,"abstract":"","PeriodicalId":19804,"journal":{"name":"Pharmaceutisch weekblad. Scientific edition","volume":"14 2","pages":"60"},"PeriodicalIF":0.0,"publicationDate":"1992-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF01980485","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"12561308","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Drug use during pregnancy. 怀孕期间使用药物。
Pharmaceutisch weekblad. Scientific edition Pub Date : 1992-04-24 DOI: 10.1007/BF01980484
P C Pasker-De Jong, T K Eskes, P W Van Dongen, K L Bos
{"title":"Drug use during pregnancy.","authors":"P C Pasker-De Jong, T K Eskes, P W Van Dongen, K L Bos","doi":"10.1007/BF01980484","DOIUrl":"https://doi.org/10.1007/BF01980484","url":null,"abstract":"","PeriodicalId":19804,"journal":{"name":"Pharmaceutisch weekblad. Scientific edition","volume":"14 2","pages":"59"},"PeriodicalIF":0.0,"publicationDate":"1992-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF01980484","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"12697813","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Stability of total parenteral nutrition supplied as 'all-in-one' for children with chemotherapy-linked hyperhydration. 化疗相关性水合过度儿童全肠外营养“一体化”的稳定性
Pharmaceutisch weekblad. Scientific edition Pub Date : 1992-04-24 DOI: 10.1007/BF01980482
M J Korrenhof, J G Timmer
{"title":"Stability of total parenteral nutrition supplied as 'all-in-one' for children with chemotherapy-linked hyperhydration.","authors":"M J Korrenhof,&nbsp;J G Timmer","doi":"10.1007/BF01980482","DOIUrl":"https://doi.org/10.1007/BF01980482","url":null,"abstract":"<p><p>The maximal allowable concentrations of calcium and phosphate in total parenteral nutrition mixtures for children from one compartment were investigated. Children treated with both chemotherapy and total parenteral nutrition are supplied with high amounts of electrolytes (besides normal nutritive needs) in a restricted volume. Such nutritive mixtures are suspected of precipitation and disintegration of the lipid emulsion by (polyvalent) electrolytes, such as calcium and phosphate. Calcium (range 1.5-150 mmol/l total parenteral nutrition) and phosphate (range 21-300 mmol/l) were added to a test total parenteral nutrition mixture. After storage (24 and 48 h) at both 22 degrees C and 37 degrees C the mixtures were observed by microscopy for the presence of precipitates. The stability of the fat emulsion was visually assessed and the particle size distribution was measured by flow cytometry. The examined total parenteral nutrition mixtures (pH 5.4-5.7) were stable during 48 h at 37 degrees C if the calcium concentration is below 16 mmol/l, the phosphate concentration is below 52 mmol/l and the product of both concentrations is below 250 mmol2/l2.</p>","PeriodicalId":19804,"journal":{"name":"Pharmaceutisch weekblad. Scientific edition","volume":"14 2","pages":"50-4"},"PeriodicalIF":0.0,"publicationDate":"1992-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF01980482","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"12697896","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Is Recormon less painful than Eprex after subcutaneous administration? 雷蒙皮下给药后疼痛是否比依普雷克斯轻?
Pharmaceutisch weekblad. Scientific edition Pub Date : 1992-04-24 DOI: 10.1007/BF01980483
M W Hendriks, F P Peters, P M Hooymans, T W Van de Wiel, D Janknegt, R Janknegt, J J Lohman
{"title":"Is Recormon less painful than Eprex after subcutaneous administration?","authors":"M W Hendriks,&nbsp;F P Peters,&nbsp;P M Hooymans,&nbsp;T W Van de Wiel,&nbsp;D Janknegt,&nbsp;R Janknegt,&nbsp;J J Lohman","doi":"10.1007/BF01980483","DOIUrl":"https://doi.org/10.1007/BF01980483","url":null,"abstract":"<p><p>In this study, we examined the differences in pain score after subcutaneous injection of the epoetin preparations Eprex and Recormon. Patients (n = 30) received 5 injections Eprex and 5 injections Recormon in a randomized double-blind sequence. 10 Min after receiving the injection the patient was asked to complete a visual and a verbal analogue scale and two descriptive scales. The results of 25 patients were used for statistical evaluation. The overall results indicate that there are significantly more patients reporting pain after subcutaneous injection of Eprex than after Recormon (11 versus 2 patients, p less than 0.05; McNemar test). 12 Patients reported no differences in pain. 43 Out of 123 injections Eprex and 69 out of 125 injections Recormon caused no pain (p less than 0.01; chi 2 9.455). For 4 patients Recormon was significantly (p less than 0.05) less painful than Eprex. It can be concluded that Recormon may be a less painful alternative for individual patients reporting pain after subcutaneous injection of Eprex.</p>","PeriodicalId":19804,"journal":{"name":"Pharmaceutisch weekblad. Scientific edition","volume":"14 2","pages":"55-8"},"PeriodicalIF":0.0,"publicationDate":"1992-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF01980483","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"12697812","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Handling of risk-bearing drugs during pregnancy. Do we choose less risky alternatives? 孕期高危药物的处理。我们会选择风险较小的选择吗?
Pharmaceutisch weekblad. Scientific edition Pub Date : 1992-04-24 DOI: 10.1007/BF01980480
L T De Jong-Van den Berg, P B Van den Berg, F M Haaijer-Ruskamp, M N Dukes, H Wesseling
{"title":"Handling of risk-bearing drugs during pregnancy. Do we choose less risky alternatives?","authors":"L T De Jong-Van den Berg,&nbsp;P B Van den Berg,&nbsp;F M Haaijer-Ruskamp,&nbsp;M N Dukes,&nbsp;H Wesseling","doi":"10.1007/BF01980480","DOIUrl":"https://doi.org/10.1007/BF01980480","url":null,"abstract":"<p><p>The drug use of nearly 2,000 pregnant women was evaluated at the level of the individual patient for the drugs belonging to the Australian risk categories B3, C and D. The pattern of changes in the use of these drugs is studied in terms of women who discontinue (d), continue (c) or begin (b) using the drug during pregnancy. The ratios d/(c+b) and d/b were the highest for the drugs belonging to the high-risk groups and the lowest for drugs from the low-risk categories. This suggests a congruence between theoretical knowledge and daily practice. Patients who had already been using a drug for a long time before pregnancy, more frequently continued using that drug than patients who had been using the drug only incidentally before. The described daily dose for the riskful drugs was approximately 20% lower in patients who started to use a drug during pregnancy compared to those who continued drug use. The data from this analysis indicate that the prescribing physician is generally aware of the possible risks of drug use during pregnancy. The d/(b+c) and d/b ratios are shown to be a good measure of prescribing behaviour in relation to pregnancy and can be used to compare knowledge of theory and daily practice.</p>","PeriodicalId":19804,"journal":{"name":"Pharmaceutisch weekblad. Scientific edition","volume":"14 2","pages":"38-45"},"PeriodicalIF":0.0,"publicationDate":"1992-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF01980480","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"12697894","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Liquid chromatographic estimation of tranylcypromine in human plasma. 人血浆中丙基环丙胺的液相色谱测定。
Pharmaceutisch weekblad. Scientific edition Pub Date : 1992-04-24 DOI: 10.1007/BF01980481
P G Krugers Dagneaux, C P Loohuis, J T Klein Elhorst, T S Van der Veer
{"title":"Liquid chromatographic estimation of tranylcypromine in human plasma.","authors":"P G Krugers Dagneaux,&nbsp;C P Loohuis,&nbsp;J T Klein Elhorst,&nbsp;T S Van der Veer","doi":"10.1007/BF01980481","DOIUrl":"https://doi.org/10.1007/BF01980481","url":null,"abstract":"<p><p>A simple, selective and quantitative estimation of tranylcypromine using liquid chromatography and electrochemical detection with apomorphine as internal standard in human plasma is described. Sample preparation is done by liquid-liquid extraction. The absolute mean recovery of apomorphine is 95%, the recovery of tranylcypromine is 81%. This method gives a simple estimation method to assay plasma concentrations of tranylcypromine in the therapeutic range (5-200 ng/ml) with good reproducibility and linearity.</p>","PeriodicalId":19804,"journal":{"name":"Pharmaceutisch weekblad. Scientific edition","volume":"14 2","pages":"46-9"},"PeriodicalIF":0.0,"publicationDate":"1992-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF01980481","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"12697895","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Therapeutic decision making of physicians. 医生的治疗决策。
Pharmaceutisch weekblad. Scientific edition Pub Date : 1992-02-21 DOI: 10.1007/BF01989219
P Denig, F M Haaijer-Ruskamp
{"title":"Therapeutic decision making of physicians.","authors":"P Denig,&nbsp;F M Haaijer-Ruskamp","doi":"10.1007/BF01989219","DOIUrl":"https://doi.org/10.1007/BF01989219","url":null,"abstract":"<p><p>In this review the therapeutic decision-making process of physicians is described. This process is divided into two steps: the generation of a limited set of possible options (the 'evoked set') and the selection from this evoked set of a treatment for a specific patient. Factors that are important in both steps are reviewed. Behavioural and decision-making theories in general and decision-making analysis of physicians in particular are discussed to identify possible shortcomings in their decision-making process. Based on this information a model of the drug choice process is presented. With reference to this model possible ways of influencing drug choices of physicians are discussed.</p>","PeriodicalId":19804,"journal":{"name":"Pharmaceutisch weekblad. Scientific edition","volume":"14 1","pages":"9-15"},"PeriodicalIF":0.0,"publicationDate":"1992-02-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF01989219","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"12721638","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 43
Enzyme inhibition in Cardiovascular disease, Weesp, The Netherlands, 13 December 1991. Abstracts. 心血管疾病中的酶抑制,Weesp,荷兰,1991年12月13日。摘要。
{"title":"Enzyme inhibition in Cardiovascular disease, Weesp, The Netherlands, 13 December 1991. Abstracts.","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":19804,"journal":{"name":"Pharmaceutisch weekblad. Scientific edition","volume":"14 1 Suppl B","pages":"B1-11"},"PeriodicalIF":0.0,"publicationDate":"1992-02-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"12905085","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pharmacokinetics of amoxycillin in elderly in-patients. 老年住院患者阿莫西林的药代动力学。
Pharmaceutisch weekblad. Scientific edition Pub Date : 1992-02-21 DOI: 10.1007/BF01989222
R Janknegt, J Boogaard-Van den Born, B A Hameleers, P M Hooymans, J Rang, C A Smits, M E Willems-Thissen
{"title":"Pharmacokinetics of amoxycillin in elderly in-patients.","authors":"R Janknegt,&nbsp;J Boogaard-Van den Born,&nbsp;B A Hameleers,&nbsp;P M Hooymans,&nbsp;J Rang,&nbsp;C A Smits,&nbsp;M E Willems-Thissen","doi":"10.1007/BF01989222","DOIUrl":"https://doi.org/10.1007/BF01989222","url":null,"abstract":"<p><p>The pharmacokinetics of amoxycillin (500 mg) given by intravenous injection and as two oral formulations on three consecutive days were investigated in eight frail elderly in-patients. Marked interindividual variation was found in all kinetic parameters after intravenous injection. The area under the curve (AUC) ranged from 32 to 155 mg.l-1.h and the distribution volume ranged from 13 to 37.1. The mean plasma clearance was 109 ml/min (range 53 to 255 ml/min). Elimination half-life ranged from 1.6 to 3.0 h (mean 2.4 h). The absolute bioavailability after oral administration was highly variable and ranged from 24 to 86% (mean 55%). The bioavailability of the two formulations was not significantly different. The performance of a pharmacokinetic study in these patients was very difficult, regarding their inability to tolerate an intravenous infusion, incontinence, disruption of everyday routine and problems with drinking the required volume of water.</p>","PeriodicalId":19804,"journal":{"name":"Pharmaceutisch weekblad. Scientific edition","volume":"14 1","pages":"27-9"},"PeriodicalIF":0.0,"publicationDate":"1992-02-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF01989222","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"12721637","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 10
Drug use in non-hospitalized children. 非住院儿童的药物使用情况
Pharmaceutisch weekblad. Scientific edition Pub Date : 1992-02-21 DOI: 10.1007/BF01989218
E J Sanz
{"title":"Drug use in non-hospitalized children.","authors":"E J Sanz","doi":"10.1007/BF01989218","DOIUrl":"https://doi.org/10.1007/BF01989218","url":null,"abstract":"<p><p>The knowledge of the characteristics of the use of drugs in non-hospitalized children is of paramount importance since clinical trials are seldom (and sometimes should not be) performed in such patients. The source of drug prescriptions varies a lot: 'self-administration' through parents accounts for as much as formal physician's orders or pharmacist's counselling. Data can be collected through the whole drug chain: drug prescription--drug dispensing--drug attainment--drug consumption. Both qualitative and quantitative data are to be collected in order to draw a complete picture of drug use in non-hospitalized children. Longitudinal collection methods, as well as time-point or cross-sectional studies can be carried out. The particular role of each of these methods of performing a drug utilization study in children are analysed and discussed.</p>","PeriodicalId":19804,"journal":{"name":"Pharmaceutisch weekblad. Scientific edition","volume":"14 1","pages":"1-8"},"PeriodicalIF":0.0,"publicationDate":"1992-02-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF01989218","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"12721634","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信